Welcome to the e-CCO Library!

P0246: Predicting Operative Recurrence in Crohn's Disease Using a Nomogram Incorporating Histopathological Factors
Year: 2025
Source: ECCO'25
Authors: Zhangx7x7x7 C.(1)*;Zhangx7x7x7 Y.(1);Xiongx7x7x7 S.(1);Zhangx7x7x7 P.(1);Caox7x7x7 Q.(2);Yex7x7x7 Z.(2);Qiux7x7x7 Y.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0247: Clinical and Colonoscopic Features of Colitis in HIV-Positive Patients Mimicking Inflammatory Bowel Disease Over the Past 12 Years
Year: 2025
Source: ECCO'25
Authors: KimProf. Dr.x7x7x7 W.J.(1)*;Choix7x7x7 Y.S.(1);Kimx7x7x7 J.K.(1);Paikx7x7x7 N.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0248: Insomnia as a determinant of poor IBD disease course
Year: 2025
Source: ECCO'25
Authors: Weintraubx7x7x7 Y.(1)*;Taumanx7x7x7 R.(2);Shouval x7x7x7 D.S.(1);Shamirx7x7x7 R.(1);Kwapiszx7x7x7 L.(3);Rosenbergx7x7x7 S.(4);Dunietzx7x7x7 G.L.(5);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0249: The Impact of Obesity on the Persistence of Advanced Therapies in Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Hsux7x7x7 W.C.(1)*;Linx7x7x7 S.H.(1x7x7x72);Chiux7x7x7 H.Y.(3);Kuox7x7x7 C.J.(1x7x7x74x7x7x75x7x7x76x7x7x77);Chenx7x7x7 C.M.(4x7x7x78);Sux7x7x7 M.Y.(1x7x7x72x7x7x74x7x7x75x7x7x76);Wux7x7x7 R.C.(1x7x7x74x7x7x79);Chiux7x7x7 C.T.(1x7x7x74x7x7x75x7x7x76x7x7x77);Changx7x7x7 C.W.(5x7x7x710x7x7x711x7x7x712);Huangx7x7x7 T.Y.(5x7x7x713);Panx7x7x7 Y.B.(14);Lex7x7x7 P.H.(1x7x7x74x7x7x75x7x7x76x7x7x77);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P024: CD40 and key CD40/CD154 pathway members are significantly upregulated in inflamed lesional IBD biopsies as shown by whole transcriptome AmpliSeq gene expression profiling and corresponding immunohistochemistry.
Year: 2022
Source: ECCO'22
Authors: Raulf, F.(1);Delucis-Bronn, C.(1);Angevaare, E.(1);Caesar, N.(1);Marcantonio, A.(1);Ceci, M.(1);Regnier, C.(1);Bonal, C.(2);Siegel, R.(2);Niess, J.H.(3);Wieczorek, G.(1);Hrúz, P.(3);
Created: Friday, 11 February 2022, 3:52 PM
P024: Development of a treatment for short bowel syndrome using small intestinal organoids
Year: 2021
Source: ECCO'21 Virtual
Authors: Sugimoto, S.(1);Kobayashi, E.(2);Fujii, M.(3);Ohta, Y.(3);Ishikawa, K.(1);Nanki, K.(1);Hakamata, Y.(4);Kanai, T.(5);Sato, T.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P024: Effects of anti-TNF and anti-interleukins 12 and 23 drugs on circulating dendritic cells migratory capacity in inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Soleto, I.(1)*;Ramirez, C.(1);Gómez, C.(1);Montse, B.(1);García, S.(1);Orejudo, M.(1);Mecado, J.(1);Chaparro, M.(1);P. Gisbert, J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P024: Plasma acetic acid, propanoic acid, and isobutyric acid are associated with treatment response in pouchitis patients treated with antibiotics
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Segal*1, M. Sarafian2, J. I. Serrano Contreras2, A. Pechlivanis2, Y. Siaw3, S. Clark1,2, L. Braz1,2, E. Holmes2, A. Hart1,2

Created: Friday, 22 February 2019, 9:41 AM
P024: Serum IL-10 is the best inflammatory variable to explain anti-TNF trough levels in a cohort of patients with Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Almenara, A. Gutiérrez, L. Sempere, P. Zapater, J. Cameo, J. González-Navajas, R. Francés*

Created: Thursday, 21 February 2019, 9:14 AM
P024: Stratification of ulcerative colitis patients according to distinctive tissue cytokine profiles
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Butera A.*1, De Nitto D.2, Ciamberlano B.3, Giuliani A.4, Pica R.2, Pronio A.5, Boirivant M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P024: Therapeutic potential of the human amniotic fluid mesenchymal stem cells/stroma cells secreted molecules in a mice model of colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Gazouli*1, E. Legaki1, M. Roubelakis1, A. Lazaris2, G. Karamanolis3, E. Marinos1, G. Theodoropoulos4

Created: Friday, 22 February 2019, 9:49 AM
P025 Evaluation of endoplasmic reticulum stress in intestinal mucosa from patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

B. Rodrigues1, L.B. Pascoal1, A. Coope1, M.L.S. Ayrizono1, M.G. Camargo1, L.A. Velloso2, J.J. Fagundes1, R.F. Leal1

Created: Thursday, 30 January 2020, 10:12 AM
P0250: Circulating blood matrix metalloproteinase (MMP)-10 and 12 can accurately predict mucosal healing in Inflammatory Bowel Disease (IBD) in a multi-centred prospective longitudinal cohort study (2020-2024).
Year: 2025
Source: ECCO'25
Authors: Cartlidgex7x7x7 P.(1)*;Whelanx7x7x7 R.(1);Siu-Ying Laux7x7x7 P.(1);Hallx7x7x7 R.(2);Chuahx7x7x7 C.S.(3);Shafix7x7x7 L.(4);Hodgex7x7x7 M.(1);Ongx7x7x7 S.(1);Le Saint-Grantx7x7x7 A.(1);Brownsonx7x7x7 E.(5);Campbellx7x7x7 I.(5);Oddyx7x7x7 A.(6);Poulosex7x7x7 B.(6);Mowatx7x7x7 C.(2);MacDonaldx7x7x7 J.(7);Seenanx7x7x7 J.P.(5);Hox7x7x7 G.T.(1);Kallax7x7x7 R.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0251: Inter-rater disagreements in applying the Montreal classification for Crohn’s disease: The Five-Nations Survey Study
Year: 2025
Source: ECCO'25
Authors: Ukashix7x7x7 O.(1x7x7x72)*;Amiotx7x7x7 A.(3);Lahariex7x7x7 D.(4);Menchénx7x7x7 L.(5x7x7x76);Gutierrezx7x7x7 A.(7);Fernandesx7x7x7 S.(8x7x7x79);Pessarellix7x7x7 T.(10);Correiax7x7x7 F.(11);Gonzalez-Muñozax7x7x7 C.(12x7x7x713);López-Cardonax7x7x7 J.(14);Barreiro-de Acostax7x7x7 M.(15x7x7x716);Yanaix7x7x7 H.(2x7x7x717);Armuzzix7x7x7 A.(18x7x7x719);Magrox7x7x7 F.(20);Kopylovx7x7x7 U.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0252: Mild Crohn’s disease is associated with altered sphingolipid metabolism and reduced neutrophilic inflammation
Year: 2025
Source: ECCO'25
Authors: Bourgonjex7x7x7 A.R.(1)*;Ibingx7x7x7 S.(2x7x7x73);Argmannx7x7x7 C.(1);Sandsx7x7x7 B.E.(1);Dubinskyx7x7x7 M.C.(1);Jacobsenx7x7x7 H.A.(4x7x7x75);Larsenx7x7x7 L.(4x7x7x75);Jessx7x7x7 T.(4x7x7x75);Rajauriax7x7x7 P.(1);Shapirox7x7x7 J.M.(6);Shahx7x7x7 S.A.(7);Ananthakrishnanx7x7x7 A.N.(8);Suarez-Fariñasx7x7x7 M.(9);Renardx7x7x7 B.Y.(2);Colombelx7x7x7 J.F.(1);Ungarox7x7x7 R.C.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0253: Identification of baseline Pediatric Crohn’s disease location and complications: How do intestinal ultrasound and magnetic resonance enterography compare?
Year: 2025
Source: ECCO'25
Authors: Morrisseyx7x7x7 M.(1)*;Hudsonx7x7x7 A.(1);Huynhx7x7x7 H.Q.(1);Carrollx7x7x7 M.W.(1);Winex7x7x7 E.(1);Thompsonx7x7x7 A.(2);Isaacx7x7x7 D.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0254: Cost of telemonitoring with the App TECCU in Inflammatory Bowel Disease compared to standard care in Spain: a multicenter clinical trial of GETECCU
Year: 2025
Source: ECCO'25
Authors: Aguas Perisx7x7x7 M.(1x7x7x72);Del Hoyo Franciscox7x7x7 J.(1x7x7x72)*;Vicente x7x7x7 R.(3);Barreiro-de Acostax7x7x7 M.(4);Maderox7x7x7 L.(5x7x7x76);Hernández-Cambax7x7x7 A.(7);Melcarnex7x7x7 L.(8);Mesonerox7x7x7 F.(9);Arroyox7x7x7 M.T.(10);Siciliax7x7x7 B.(11);Mañosax7x7x7 M.(12x7x7x713);Martín-Arranzx7x7x7 M.D.(14);Pajaresx7x7x7 R.(15);Chaparrox7x7x7 M.(16x7x7x717);Martínezx7x7x7 P.(18);Chacónx7x7x7 S.(19);Toscax7x7x7 J.(20);Calvox7x7x7 M.(21);Marínx7x7x7 S.(22);Sanrománx7x7x7 L.(23);Zabanax7x7x7 Y.(24x7x7x725);Sainzx7x7x7 E.(26);Monfortx7x7x7 D.(27);Guerrax7x7x7 I.(28);Varelax7x7x7 P.(29);Baydalx7x7x7 V.(1);Corsinox7x7x7 P.(3);Porto-Silvax7x7x7 S.(4);Gutiérrezx7x7x7 A.(5x7x7x76);Gonzálezx7x7x7 M.(7);Brunetx7x7x7 E.(8);Faubelx7x7x7 R.(30x7x7x731);Nosx7x7x7 P.(1x7x7x72);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0255: Predictive potential of microRNA expression for Juvenile Idiopathic Arthritis development in paediatric Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Dorn-Rasmussenx7x7x7 M.(1)*;Jamesx7x7x7 J.P.(2);Malhamx7x7x7 M.(3);Burischx7x7x7 J.(4);Ingelsx7x7x7 H.A.S.(5);Riisx7x7x7 L.B.(2);Wewerx7x7x7 V.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0256: Histologically-proven isolated cuffitis and quality of life among patients with ileoanal pouch
Year: 2025
Source: ECCO'25
Authors: Fischmanx7x7x7 M.(1x7x7x72)*;Codishx7x7x7 M.(3);Barkanx7x7x7 R.(2x7x7x73);Whitex7x7x7 I.(3x7x7x74);Wasserbergx7x7x7 N.(3x7x7x74);Rabinowitzx7x7x7 K.(5);Avni-Bironx7x7x7 I.(2);Banaix7x7x7 H.(2);Snirx7x7x7 Y.(2);Yanaix7x7x7 H.(2x7x7x73);Dotanx7x7x7 I.(2x7x7x73);Ollechx7x7x7 J.(2x7x7x73);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0257: Correlation of biochemicalx7x7x7 endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial
Year: 2025
Source: ECCO'25
Authors: Pudipeddix7x7x7 A.(1x7x7x72x7x7x73)*;Dhanjix7x7x7 P.(1);Paramsothyx7x7x7 S.(1x7x7x72);Kariyawasamx7x7x7 V.(1x7x7x74);Paramsothyx7x7x7 R.(5);Ghalyx7x7x7 S.(6x7x7x77);Haiferx7x7x7 C.(7x7x7x78);Anx7x7x7 Y.K.(9x7x7x710);Begunx7x7x7 J.(9x7x7x710);Connorx7x7x7 S.(11x7x7x712);Cortex7x7x7 C.(13);Wardx7x7x7 M.(14);De Cruzx7x7x7 P.(15x7x7x716);Fungx7x7x7 C.(17);Redmondx7x7x7 D.(1);Chanx7x7x7 W.(18);Mouradx7x7x7 F.(19);Kermeenx7x7x7 M.(1);Leongx7x7x7 R.(1x7x7x72x7x7x74);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session